Every breakthrough therapy creates another difficult purchasing decision. As specialty medications, gene therapies, precision medicine, and biosimilars reshape the pharmacy landscape, employers must determine how to balance innovation, affordability, and long-term sustainability. This session explores practical strategies for managing the pipeline while maintaining access to high-value care.